WuXi Biologics is headquartered in Wuxi, China.
WuXi Biologics disclosed revenue of 18,675M CNY for 2024 and 17,034M CNY for 2023.
WuXi Biologics has 12,552 employees.
WuXi Biologics is a life science company.
WuXi Biologics was founded in 2014.
No. 108, Meiliang Road, Mashan Binhu District,
Wuxi,
214092
China,
www.wuxibiologics.com.cn
WuXi Biologics is an open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing. WuXi Biologics was founded in 2014 and is based in Wuxi, China.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.6/yr) | # | - | 3 | - | - | - | - | 3 |
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 3 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
